Home / Biosimilars
Biosimilars
News![]() The European Medicines Agency (EMA) is the body responsible for approval of biosimilars within the European Union (EU). A leg... ![]() The European Commission (EC) has granted marketing authorization for the pegfilgrastim biosimilar Nyvepria (PF-06881894), dev... ![]() Iceland-based biopharmaceutical company Alvotech announced on 19 November 2020 that its US subsidiary, Alvotech USA... ![]() China-based drugmaker Shanghai Henlius Biotech (Henlius) announced on 7 December 2020 that China’s National Medical Products... ![]() The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) announced on 13 November 2020 tha... |
Research![]() A survey was carried out by the World Health Organization (WHO) in 2019‒2020 covering most current topics pertinent to biosim... ![]() In Europe, the individual Member States are responsible for designing policies that regulate the market entry and use of phar... ![]() China-based drugmaker Innovent Biologics (Innovent) announced on 23 November 2020 positive results for its copy bevacizumab b... ![]() The World Health Organization (WHO) Expert Committee on Biological Standardization adopted guidelines for biosimilars at its... ![]() A poster presented at the Virtual ISPOR (International Society for Pharmacoeconomics and Outcomes Research) 2020 conference&n... |
General![]() Last update: 15 January 2021Trastuzumab is a monoclonal antibody that binds to and inactivates the human epidermal growt... ![]() Last update: 15 January 2021Pegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating fa... ![]() Australia first introduced guidelines for biosimilars back in August 2008 when it adopted a number of guidelines from the EU... ![]() Last update: 8 January 2021Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily foun... ![]() Korea-based Samsung Bioepis (Samsung and Biogen’s joint venture) has announced several advances related to its infliximab, de... |
Generics News Research General
- Perspectives of prescribing practices in public...Generics/Research | Posted 15/01/2021
- A European pharmaceutical strategy promoting ge...Generics/General | Posted 08/01/2021
- Familiarity with substitution of prescription g...Generics/Research | Posted 11/12/2020
- Cost savings after switching to generic tacrolimusGenerics/Research | Posted 04/12/2020
Biosimilars News Research General
- Biosimilars of trastuzumabBiosimilars/General | Posted 19/09/2014
- Biosimilars of pegfilgrastimBiosimilars/General | Posted 31/10/2014
- Biosimilars in Australia – a-flagging and susta...Biosimilars/General | Posted 08/01/2021
- Biosimilars of rituximabBiosimilars/General | Posted 27/02/2015